Luigi Mangione Pleads Guilty to Federal Charges in UnitedHealthcare CEO Brian Thompson’s Killing
Luigi Mangione Pleads Guilty to Federal Charges in UnitedHealthcare CEO Brian Thompson’s Killing
Luigi Mangione has pleaded guilty to federal charges connected to the 2024 killing of UnitedHealthcare CEO Brian Thompson, admitting in court that he stalked the executive and fatally shot him in Manhattan.
Mangione, 28, entered the guilty plea Friday in federal court in Manhattan, bringing the federal portion of one of the most closely watched criminal cases in the United States to a dramatic conclusion.
During the hearing, Mangione acknowledged that he traveled to New York, tracked Thompson and deliberately carried out the shooting outside a Manhattan hotel on December 4, 2024.
He pleaded guilty to two federal stalking charges that resulted in death. Each charge carries a potential sentence of life imprisonment.
Speaking in court, Mangione gave a detailed account of how he planned the attack. He admitted that he researched the location of a UnitedHealthcare investor conference and used a false identity to obtain information about the event.
He also acknowledged that he traveled across state lines as part of the plan.
Mangione told the court that he knew what he was doing was illegal.
The guilty plea represents a major change from his previous position in the case. Mangione had previously pleaded not guilty to the federal charges and was preparing for a trial that could have attracted enormous public attention.
Federal prosecutors are now seeking a life sentence.
U.S. District Judge Margaret Garnett is scheduled to sentence Mangione on December 18. The judge asked him whether he understood that he could spend the rest of his life in prison, and Mangione answered that he did.
The federal case has undergone several significant changes since Mangione was arrested.
Federal prosecutors initially charged him with murder and sought the possibility of the death penalty. However, Judge Garnett later dismissed the federal murder charge and a related firearms charge, ruling that the counts were legally incompatible with the stalking charges.
The dismissal meant that Mangione could no longer face the death penalty in the federal case.
His guilty plea therefore relates to the remaining federal stalking charges rather than a federal murder conviction.
The shooting of Thompson occurred outside a hotel in Midtown Manhattan, where the UnitedHealthcare chief executive was scheduled to attend an investor conference.
Surveillance footage captured the attack and showed a masked gunman approaching Thompson before shooting him.
Thompson died at the scene.
The killing immediately triggered a massive police investigation and a nationwide manhunt. Mangione was arrested five days later in Altoona, Pennsylvania.
Authorities said he was carrying a 3D-printed handgun and other items when he was taken into custody.
The case quickly became a national political and cultural story because of widespread anger over the American health insurance system.
Mangione’s lawyers have previously indicated that he experienced significant frustration with the healthcare system after suffering a serious back injury.
During Friday’s hearing, Mangione described his personal experiences and said they contributed to his decision to target UnitedHealthcare.
However, prosecutors have strongly rejected any suggestion that anger over the healthcare industry could justify the killing.
Thompson’s family attended the federal hearing and reacted emotionally as Mangione admitted to the shooting.
In a statement after the plea, Thompson’s family described the guilty plea as an important step toward accountability while emphasizing that the case is not completely finished.
Mangione still faces separate criminal charges in New York state stemming from Thompson’s killing.
The state case is significant because prosecutors there have charged Mangione with second-degree murder. A state trial had been scheduled to begin in September.
However, the guilty plea in federal court has created a new legal battle.
Mangione’s defense attorneys are seeking to have the New York state prosecution dismissed under double-jeopardy principles.
The lawyers argue that allowing the state case to continue after the federal guilty plea could amount to prosecuting Mangione twice for the same conduct.
State prosecutors strongly oppose that argument and have indicated that they intend to continue pursuing the case.
The legal question could ultimately require further appeals and judicial review.
For now, the federal guilty plea provides prosecutors with a clear admission that Mangione stalked and killed Thompson.
Mangione’s statement in court was unusually detailed. He described researching the UnitedHealthcare conference, posing as an investor and traveling to New York before carrying out the attack.
He also admitted that he used a weapon that he had made with the assistance of a 3D printer.
The case has drawn extraordinary public attention since Thompson’s death.
Mangione has received both condemnation and expressions of support from different groups, particularly among people angry about insurance coverage decisions and the broader U.S. healthcare system.
His supporters have portrayed him as someone who exposed problems in the healthcare industry, while prosecutors and Thompson’s family have emphasized that those grievances cannot excuse murder.
The killing also sparked a wider national discussion about healthcare costs, insurance denials and the role of corporate executives.
UnitedHealthcare is one of the largest health insurance companies in the United States, and Thompson was leading the company when he was killed.
His death shocked the business community and prompted increased security concerns among corporate executives.
The guilty plea now means that Mangione will not face a federal trial.
Instead, the next major step in the federal case will be his sentencing in December.
Prosecutors are expected to argue for a life sentence based on the deliberate nature of the crime and the planning that preceded the shooting.
Mangione’s defense team could argue for a lesser sentence, although the maximum possible punishment on the federal charges is life imprisonment.
The outcome of the separate New York case remains uncertain.
If the state prosecution survives Mangione’s double-jeopardy challenge, he could still face another trial and potentially another lengthy prison sentence.
The state case could also become more complicated because of the admissions he made during the federal plea hearing.
Mangione’s lawyers are likely to examine the legal consequences of those statements as they continue fighting the state prosecution.
For Thompson’s family, Friday’s guilty plea represents an important acknowledgment of responsibility after nearly two years of legal proceedings.
But the family has made clear that it continues to seek justice through the remaining legal process.
The case has already become one of the most closely followed criminal proceedings involving a corporate executive in recent American history.
It has generated intense debate over violence, healthcare policy, corporate accountability and the public reaction to high-profile crimes.
Mangione’s guilty plea does not resolve those broader social debates.
It does, however, establish his admission of responsibility for stalking Thompson and carrying out the fatal shooting.
As the case moves toward sentencing, attention will turn to whether the judge imposes the life sentence sought by prosecutors and whether the New York state murder case can proceed.
For now, the federal case has reached a decisive point.
Luigi Mangione has admitted in open court that he stalked Brian Thompson and shot him in Manhattan.
His guilty plea closes the federal trial that once appeared likely to dominate national headlines, but the legal battle surrounding the killing is far from over.
About the Author
